Scouts
What context makes a scout introduction of a healthcare software startup useful?
a healthcare software startup: A useful introduction connects the founder's specific need with the recipient's actual mandate.
A useful introduction connects the founder's specific need with the recipient's actual mandate. Include the company workflow, stage, evidence, fundraising context, and why the scout believes the conversation is relevant. Get consent before forwarding private materials.
Start with the decision
Write a concise introduction both sides can understand without a long prior thread. State the scout's relationship and limits. Share only the materials the founder approved and make the requested next step explicit.
The illustrative scenario
This is an educational workbook. The company or fund and all numerical inputs below are fictional. They are not ADIN results, customer claims, market benchmarks, or a forecast.
The fictional team is piloting an administrative scheduling product with a provider group. Staff use it in a narrow workflow, while procurement and data review determine whether a broader rollout is possible.
A clinic's enthusiasm does not resolve data handling, workflow ownership, or applicable regulatory questions. This example does not assume a particular legal classification or approval.
Turn the scenario into an evidence decision
Consider a review of a healthcare software startup in which a confident explanation arrives before the supporting records. Start with the first question in the table. Write down what an answer would change: the next interview, the experiment's scope, a request for specialist review, or a decision to wait. A question without a consequence can produce a longer document while adding little understanding.
Next, inspect the record named in the table and record its date, owner, permission boundary, and limitations. Review authorized workflow observations, procurement requirements, permissioned usage evidence, and specialist advice about applicable obligations. Avoid using identifiable patient information in a diligence packet. If the record contradicts the explanation, preserve both accounts and ask which definition, period, or workflow differs. Do not silently select the version that makes the opportunity look strongest.
Finish with a conditional statement: if the specified evidence supports the claim under these conditions, take the named next step; otherwise investigate the unresolved question. An introduction opens a conversation; it does not endorse every claim or imply that a fund has approved an investment. Protect the relationship by keeping expectations and the source of information clear. This worked exercise is about the decision process. It does not assert that a fictional company has met a real diligence standard or that a template can authorize an investment.
| Item | Illustration |
|---|---|
| Decision question | What does the founder want? |
| Case-specific constraint | A clinic's enthusiasm does not resolve data handling, workflow ownership, or applicable regulatory questions. This example does not assume a particular legal classification or approval. |
| Record to inspect | Review authorized workflow observations, procurement requirements, permissioned usage evidence, and specialist advice about applicable obligations. Avoid using identifiable patient information in a diligence packet. |
| Comparison to preserve | Compare the administrative workflow and rollout dependencies with the current process. Do not treat an operational pilot as clinical efficacy evidence. |
| Unresolved case question | Which workflow is actually in scope? |
Use this worksheet
Answer the questions with a source, date, owner, and next action. Mark an unknown as unknown. Use public or permissioned information and involve a qualified specialist when a question requires expertise beyond the team’s competence.
- What does the founder want?
- Why does the fund fit?
- What context is approved for sharing?
- What is directly known?
- What next step is requested?
Questions specific to this scenario
- Which workflow is actually in scope?
- Who approves data access?
- What specialist review is needed?
Review authorized workflow observations, procurement requirements, permissioned usage evidence, and specialist advice about applicable obligations. Avoid using identifiable patient information in a diligence packet.
A concrete next test
Ask the authorized workflow owner to map a narrow administrative use case without disclosing patient information. Identify the data-access and procurement approvals needed for the next step. Keep operational adoption evidence separate from claims about clinical benefit or regulatory status.
Interpret the result
An introduction opens a conversation; it does not endorse every claim or imply that a fund has approved an investment. Protect the relationship by keeping expectations and the source of information clear.
Compare the administrative workflow and rollout dependencies with the current process. Do not treat an operational pilot as clinical efficacy evidence.
Sources and method
These primary resources provide background for the concepts. The fictional scenario, calculations, and worksheet are ADIN educational examples; the sources do not report or validate those invented results. Reviewed October 11, 2026.